GlassScriptPhysician profile
Shradha Samuel
NPI 1922528207
$9,426.84
in general payments reported to CMS, 2019-2025
13 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.63 · 2022: $5,066 · 2023: $3,736 · 2024: $314 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,333 · Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,333.00 |
| Food and Beverage | $1,007.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,800.74 | 2022-2023 | Endurant Iis, Hawkone |
| W. L. Gore & Associates, INC. | $942.53 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Integra Lifesciences Corporation | $177.20 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Penumbra, INC. | $158.46 | 2023 | Penumbra System |
| Endologix LLC | $120.50 | 2022 | |
| Cook Medical LLC | $73.94 | 2024-2025 | Rosen, Zenith, Zilver Ptx |
| Amgen INC. | $35.60 | 2024 | Repatha |
| Abbott Laboratories | $29.35 | 2024 | Jeti Peripheral Catheter |
| Altathera Pharmaceuticals LLC | $24.50 | 2024 | Sotalol Hydrochloride |
| Davol INC. | $19.63 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.19 | 2024 | Farxiga |
| Cordis US Corp. | $14.22 | 2024 | Radial 360 |
| Haemonetics Corporation | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shradha Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.